Incannex Healthcare Inc
For the period ended Dec 31, 2023. Filed Feb 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2023 · Filed Feb 14, 2024
IXHL$2.01-8.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
Consolidated Statements of Stockholders’ Equity (Deficit)
(in thousands, except share amounts)
| Common stock · Additional paid-in capital · Accumulated deficit · Foreign currency translation reserve · Total stockholders’ equity (deficit) | ||||||
|---|---|---|---|---|---|---|
| Share | Amount | Amount | Amount | Amount | Amount | |
| # | $ | $ | $ | $ | $ | |
| Balance at June 30, 2023 | 15,873,113 | 2 | 116,290 | (92,212) | (3,255) | 20,825 |
| Share-based compensation | - | - | 201 | - | - | 201 |
| Net loss | - | - | - | (726) | - | (726) |
| Currency translation adjustment, net of tax | - | - | - | - | (510) | (510) |
| Balance at September 30, 2023 | 15,873,113 | 2 | 116,491 | (92,938) | (3,765) | 19,790 |
| Share-based compensation | - | - | 3,396 | - | - | 3,396 |
| Net loss | - | - | - | (5,241) | - | (5,241) |
| Currency translation adjustment, net of tax | - | - | - | - | 927 | 927 |
| Balance at December 31, 2023 | 15,873,113 | 2 | 119,887 | (98,179) | (2,838) | 18,872 |
Consolidated Statements of Stockholders’ Equity (Deficit) (Continued)
(in thousands, except share amounts)
| Common stock · Additional paid-in capital · Accumulated deficit · Foreign currency translation reserve · Total Stockholders’ Equity (Deficit) | ||||||
|---|---|---|---|---|---|---|
| Share | Amount | Amount | Amount | Amount | Amount | |
| # | $ | $ | $ | $ | $ | |
| Balance at June 30, 2022 | 12,926,349 | 1 | 69,074 | (43,401) | (963) | 24,711 |
| Options exercised | - | - | - | - | - | - |
| Options issued to advisors | - | - | 476 | - | - | 476 |
| Option placements | - | - | - | - | - | - |
| Share-based compensation | - | - | 1,099 | - | - | 1,099 |
| Share placements | 634,146 | - | 8,830 | - | - | 8,830 |
| Share issued to advisors | 130,902 | - | 2,050 | - | - | 2,050 |
| Asset acquisition shares issued | 2,181,695 | 1 | 34,170 | - | - | 34,171 |
| Issuance costs | - | - | (530) | - | - | (530) |
| Net loss | - | - | - | (41,066) | - | (41,066) |
| Currency translation adjustment, net of tax | - | - | - | - | (1,827) | (1,827) |
| Balance at December 31, 2022 | 15,873,092 | 2 | 115,169 | (84,467) | (2,790) | 27,914 |
| Options exercised | 21 | - | 1 | - | - | 1 |
| Options issued to advisors | - | - | - | - | - | - |
| Option placements | - | - | 71 | - | - | 71 |
| Share-based compensation | - | - | 1,049 | - | - | 1,049 |
| Share placements | - | - | - | - | - | - |
| Share issued to advisors | - | - | - | - | - | - |
| Asset acquisition shares issued | - | - | - | - | - | - |
| Issuance costs | - | - | - | - | - | - |
| Net loss | - | - | - | (7,745) | - | (7,745) |
| Currency translation adjustment, net of tax | - | - | - | - | (465) | (465) |
| Balance at June 30, 2023 | 15,873,113 | 2 | 116,290 | (92,212) | (3,255) | 20,825 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.